Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Available 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia 23Prostatic Neoplasms 12Lymphoma 11Burkitt Lymphoma 9Lymphoma, Large B-Cell, Diffuse 4Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Dendritic Cell Sarcoma, Interdigitating 3Anemia, Refractory, with Excess of Blasts 3Recurrence 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Hodgkin Disease 2Anemia, Refractory 2Stomatitis 1Rhabdoid Tumor 1Pituitary Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Oral Ulcer 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms × Hydrocortisone × Clear all
NCT00185692 2019-12-04

Allogeneic Transplantation From Related Haploidentical Donors

Stanford University

Phase 2 Completed
16 enrolled 8 charts
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡